169 related articles for article (PubMed ID: 25509318)
1. [Situation analysis for drug clinical trial institutions].
Chen YY; Wu P; Wang J
Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3208-10. PubMed ID: 25509318
[TBL] [Abstract][Full Text] [Related]
2. [Significance of re-evaluation and development of Chinese herbal drugs].
Gao Y; Ma Z; Zhang B
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):1-4. PubMed ID: 22741451
[TBL] [Abstract][Full Text] [Related]
3. [Closed-loop management model of clinical investigational product for new drug of traditional Chinese medicine].
Wu P; Zhang JW
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(17):2898-900. PubMed ID: 24380320
[TBL] [Abstract][Full Text] [Related]
4. [Research on our hospital inventory management status quo of traditional Chinese medicine drugs and treatment method].
Zhang YN; Xu W
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(6):1140-2. PubMed ID: 24956868
[TBL] [Abstract][Full Text] [Related]
5. [Risk control system construction of Shenfu injection].
Tian DL; Li K; Jiang JJ; Zhu YN
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2814-7. PubMed ID: 23285942
[TBL] [Abstract][Full Text] [Related]
6. [A discussion of key issues on postmarketing reevaluation of Chinese medicine].
Xie Y; Tian F
Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1494-7. PubMed ID: 20822029
[TBL] [Abstract][Full Text] [Related]
7. [Postmarketing herbs clinical evaluation should concern about re-evaluating symptoms].
He W; Xie Y; Wang Y
Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1498-500. PubMed ID: 20822030
[TBL] [Abstract][Full Text] [Related]
8. [Clinical orientation of post-marketing Chinese patent drugs: an evidence-based practice].
Shang HC; Zhang BL; Li YP
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):887-90. PubMed ID: 18782528
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on reasons for disapproval of registration application of new traditional Chinese medicines in recent years].
Zhang X; Zhang L; Wang H
Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2333-7. PubMed ID: 23193572
[TBL] [Abstract][Full Text] [Related]
10. [Problems in medicinal materials research of new traditional Chinese medicine].
Zhou G; Wang T; He YP
Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3192-5. PubMed ID: 25509314
[TBL] [Abstract][Full Text] [Related]
11. Asian medicine. The new face of traditional Chinese medicine.
Normile D
Science; 2003 Jan; 299(5604):188-90. PubMed ID: 12522228
[No Abstract] [Full Text] [Related]
12. [Expert consensus on key issues of quality control in clinical trials of new drugs of traditional Chinese medicine].
Yuan WA; Tang JY; Gao R; Hu SY; Zhao YL; Zou C; Li B; Zhang JH; Zhang L; Yang ZQ
Zhongguo Zhong Yao Za Zhi; 2021 Apr; 46(7):1701-1705. PubMed ID: 33982472
[TBL] [Abstract][Full Text] [Related]
13. The bright future of Chinese herbal medicine: only after a twisty road.
Ye XF; He J
Contemp Clin Trials; 2010 Nov; 31(6):508-9. PubMed ID: 20674776
[TBL] [Abstract][Full Text] [Related]
14. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
[TBL] [Abstract][Full Text] [Related]
15. [Status and thinking of supervision and management of Chinese herbal medicine].
Xie XY
Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(11):1832-5. PubMed ID: 24010306
[TBL] [Abstract][Full Text] [Related]
16. [Development of quality traceability system of traditional Chinese medicine].
Cai Y; Hu H; Ni JY; Wang YT
Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3829-33. PubMed ID: 24558859
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
18. [Application of traditional Chinese medicine reference standards in quality control of Chinese herbal pieces].
Lu TL; Li JC; Yu JY; Cai BC; Mao CQ; Yin FZ
Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):149-52. PubMed ID: 24754185
[TBL] [Abstract][Full Text] [Related]
19. [Problems in preparation of toxic herbs in process of research and development of new traditional Chinese medicine of rheumatism, orthopedics and surgery].
Wang T; Zhou G
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2653-5. PubMed ID: 23236771
[TBL] [Abstract][Full Text] [Related]
20. [Some issues to notice in the research and quality evaluation of external preparations of traditional Chinese medicine].
Jin F
Zhongguo Zhong Yao Za Zhi; 2010 Nov; 35(21):2934-6. PubMed ID: 21322963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
